Diva vaccines that reduce virus transmission

Journal of Biotechnology

Volumn 73, Issue 2-3, 1999, Pages 195-205

  Van Oirschot, J T ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Diva vaccines; Swine and cattle; Virus transmission

Indexed keywords

ANTIBODIES; ANTIGENS; DIAGNOSIS; DISEASES; PROTEINS; VIRUSES;

DIFFERENTIATING INFECTED FROM VACCINATED INDIVIDUALS; HERPESVIRUSES; PESTIVIRUSES; PSEUDORABIES; VIRUS TRANSMISSIONS;

VACCINES;

PSEUDORABIES VACCINE; VIRUS VACCINE;

BACULOVIRUS; BOVINE HERPES VIRUS; CATTLE; CATTLE DISEASE; CONFERENCE PAPER; DIAGNOSTIC TEST; FETUS; HERPES VIRUS; MOTHER; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL; PSEUDORABIES; PSEUDORABIES HERPETOVIRUS; SHEEP; SWINE; VERTICAL TRANSMISSION; VIRUS INFECTION; VIRUS TRANSMISSION;

ANIMALS; BIOTECHNOLOGY; CATTLE; CATTLE DISEASES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HERPESVIRIDAE INFECTIONS; PESTIVIRUS INFECTIONS; PREGNANCY; SHEEP; SWINE; SWINE DISEASES; VIRAL VACCINES;

BOS TAURUS; BOVINAE; BOVINE HERPESVIRUS 1; CLASSICAL SWINE FEVER VIRUS; HERPESVIRIDAE; HERPESVIRUS 1; OVIS ARIES; SUS SCROFA; UNIDENTIFIED BACULOVIRUS;

EID: 0344631092     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1656(99)00121-2     Document Type: Conference Paper

References (69)

1. Anderson J., Mertens P.P.C., Herniman K.A.J. A competitive ELISA for the detection of anti-tubule antibodies using a monoclonal antibody against Bluetongue virus non-structural protein NS1. J. Virol. Methods. 43:1993;167-176.
2. Bergmann I.E., De Mello P.A., Neitzert E., Beck E., Gomes I. Diagnosis of persistent aphtovirus infection and its differentiation from vaccination response in cattle by use of enzyme-linked immunoelectrotransfer blot analysis with bioengineered nonstructural viral antigens. Am. J. Vet. Res. 54:1993;825-831.
3. Birch-Machin I., Rowan A., Pick J., Mumford J., Binns M. Expression of the non-structural protein NS1 of equine influenza A virus: detection of anti-NS1 antibody in post infection equine sera. J. Virol. Methods. 65:1997;255-263.
4. Bolin S.R., Ridpath J.F. Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease. Arch. Virol. 141:1996;1463-1477.
5. Bosch J.C., Kaashoek M.J., Kroese A.H., Van Oirschot J.T. An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Vet. Microbiol. 52:1996;223-234.
6. Bosch, J.C., De Jong, M.C.M., Van Bree, J., Van Oirschot, J.T., 1997. Quantification of transmission of bovine herpesvirus 1 in cattle vaccinated with marker vaccines. In: Bosch, J.C., PhD Thesis, pp. 53-66.
7. Bosch J.C., De Jong M.C.M., Franken P., Frankena K., Hage J.J., Kaashoek M.J., Maris-Veldhuis M.A., Noordhuizen J.P.T.M., Van der Poel W.H.M., Verhoeff J., Weerdmeester K., Zimmer G.M., Van Oirschot J.T. An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field. Vaccine. 16:1998;265-271.
8. Bouma A., De Jong M.C.M., Kimman T.G. Transmission of pseudorabies virus within pig populations is independent of the size of the population. Prev. Vet. Med. 23:1995;163-172.
9. Bouma A., De Jong M.C.M., Kimman T.G. Transmission of two pseudorabies virus strains, that differ in virulence and virus excretion, in groups of vaccinated pigs. Am. J. Vet. Res. 57:1996;43-47.
10. Bouma A., De Jong M.C.M., Kimman T.G. The influence of maternal immunity on the transmission of pseudorabies virus and on the effectiveness of vaccination. Vaccine. 15:1997;287-294.
11. Bourgueil E., Hutet E., Cariolet R., Vannier P. Air sampling procedure for evaluation of viral excretion level by vaccinated pigs infected with Aujeszky's disease (pseudorabies) virus. Res. Vet. Sci. 52:1992;182-186.
12. Brownlie J., Clarke M.C., Hooper L.B., Bell G.D. Protection of bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet. Rec. 137:1995;58-62.
13. Bruschke C.J.M., Moormann R.J.M., Van Oirschot J.T., Van Rijn P.A. A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge. Vaccine. 15:1997;1940-1945.
14. Castrucci G., Wada E.M., Ranucci S., Frigeri F., Cilli V., Pedini B., Tesei B., Arush M.A. Reactivation of latent infectious bovine rhino-tracheitis virus in calves. Microbiologica. 3:1980;307-318.
15. Christensen L.S., Mortensen S., Botner A., Strandbygaard B.S., Ronsholt L., Henriksen C.A., Andersen J.B. Further evidence of long distance airborne transmission of Aujeszky's disease (pseudorabies) virus. Vet. Rec. 132:1993;317-321.
16. Coria M.F., McClurkin A.W. Specific immune tolerance in an apparently healthy bull persistently infected with bovine viral diarrhea virus. J. Am. Vet. Med. Assoc. 172:1978;449-451.
17. Cortese, V.S., West, K., Ellis, J., 1996. Clinical and immunologic responses to type 2 BVDV challenge in vaccinated and unvaccinated calves. Proc. XIXth World Buiatrics Congress, Edinburgh, July 8-12, pp. 610-613.
18. De Jong M.C.M. Mathemathical modelling in veterinary epidemiology: why model building is important. Prev. Vet. Med. 25:1995;183-193.
19. De Jong M.C.M., Kimman T.G. Experimental quantification of vaccine induced reduction in virus transmission. Vaccine. 12:1994;761-766.
20. 0 for discretetime epidemic models with dynamic heterogeneity. Math. Bio. Sci. 119:1994;97-114.
21. De Smet, K., De Waele, K., Pensaert, M.B., 1992. Virulent Aujeszky's disease virus infectious dose in vaccinated and non-vaccinated pigs. Proc. 12th Int. Pig Vet. Soc. Congr., The Hague, The Netherlands, p. 65.
22. De Smet K., De Waele K., Pensaert M.B., Goovaerts D., De Ridder E. Field experiments to evaluate the feasibility of eradication of Aujeszky's disease virus by different vaccination schedules. Vet. Q. 14:1992;22-28.
23. 0 in models for infectious diseases in heterogeneous populations. J. Math. Biol. 28:1990;365-382.
24. Donaldson A.I., Wardley R.C., Martin S., Ferris N.P. Experimental Aujeszky's disease in pigs: excretion, survival and transmission of the virus. Vet. Rec. 113:1983;490-494.
25. Elbers A.R.W., Stegeman J.A. Marked reduction of the prevalence of pseudorabies virus-infected pigs in pig dense regions of the Netherlands during the first year of a nation-wide vaccination campaign. Vet. Q. 18:1996;65-67.
26. Ewald C., Schmatz H.D., Runge C., Bahnsen C., Heer A., Wuthe H.H. Bekampfung der Aujeszkyschen Krankheit in Schelswig-Holstein. 2. Mitteilung: Sanierung eines Gebietes durch Ausmerzung gI-positiver Zuchtschweine nach dreijahriger Flachenimpfung mit gI-deletierten Impfstoffen. Tierarztl. Umschau. 49:1994;751-755.
27. Gloster J., Donaldson A.I., Hough M.N. Analysis of a series of out breaks of Aujeszky's disease in Yorkshire in 1981-1982: the possibility of airborne disease spread. Vet. Rec. 114:1984;234-239.
28. Grosse Beilage E., Friedel K., Bruhn F., Bollwahn W. Die Bekämp-fung der Aujeszkyschen Krankheit mit Hilfe der Flächenimpfung und der Ausmerzung infizierter Zuchtschweine. III. Mitteilung: Eradikation der Aujeszkyschen Krankheit in infizierten Schweineherden am Beispiel des Sanierungsverfahrens im Landkreis Osnabrück/Niedersachsen. Dtsch. Tierärztl. Wschr. 104:1997;393-400.
29. Hage J.J., Schukken Y.H., Barkeman H.W., Benedictus G., Rijsewijk F.A.M., Wentink G.H. Population dynamics of bovine herpesvirus 1 infection in a dairy herd. Vet. Microbiol. 53:1996;169-180.
30. Hage, J.J., Schukken, Y.H., Schols, H., Maris-Veldhuis, M.A., Rijsewijk, F.A.M., Klaassen, C.H.L., 1997. Transmission of bovine herpesvirus 1 within and between herds on an island with a BHV1 control programme. In: Hage, J.J. PhD thesis, University Utrecht.
31. Homan E.J., Easterday B.C. Experimental latent and recrudescent bovine herpesvirus 1 infections in calves. Am. J. Vet. Res. 44:1983;309-313.
32. Hulst M.M., Westra D.F., Wensvoort G., Moormann R.J.M. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J. Virol. 67:1993;5435-5442.
33. Kaashoek M.J., Van Oirschot J.T. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine. Vet. Microbiol. 53:1996;191-197.
34. Kaashoek M.J., Moerman A., Madic J., Rijsewijk F.A.M., Quak J., Gielkens A.L.J., Van Oirschot J.T. A conventionally-attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine. 12:1994;439-444.
35. Kaashoek M.J., Moerman A., Madi_ J.A., Weerdmeester K., Maris-Veldhuis M.A., Rijsewijk F.A.M., Van Oirschot J.T. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine. 13:1995;342-346.
36. Kaashoek M.J., Straver P.J., Van Rooij E.M.A., Quak J., Van Oirschot J.T. Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1. strains: clinical and virological aspects. Vet. Rec. 139:1996;416-421.
37. Kinker D.R., Swenson S.L., Wu L.L., Zimmerman J.J. Evaluation of serological tests for the detection of pseudorabies gE antibodies during early infection. Vet. Microbiol. 55:1997;99-106.
38. Kit S. Genetically engineered vaccines for control of Aujeszky's disease (pseudorabies). Vaccine. 8:1990;420-424.
39. Kramps J.A., Van Maanen C., Van de Wetering G., Stienstra G., Quak J., Brinkhof J., Ronsholt L., Nylin B. A simple, rapid and reliable enzyme-linked immunosorbent assay for the detection of bovine virus diarrhoea virus (BVDV) specific antibodies in cattle serum, plasma and bulk milk. Vet. Microbiol. 64:1998;135-144.
40. Mars M.H., Bruschke C.J.M., Van Oirschot J.T. Aerogenic transmission of BHV1, BRSV and BVDV under experimental conditions. Vet. Microbiol. 66:1998;197-207.
41. Meyling A., Houe H., Jensen A.M. Epidemiology of bovine virus diarrhoea virus. Rev. Sci. Tech. Off. Int. Epiz. 9:1990;75-93.
42. Moerman A., Straver P.J., De Jong M.C.M., Quak J., Baanvinger Th., Van Oirschot J.T. A long term epidemiological study of bovine viral diarrhoea infections in a large herd of dairy cattle. Vet. Rec. 132:1993;622-626.
43. Moormann R.J.M., De Rover T., Briaire J., Peeters B.P.H., Gielkens A.L.J., Van Oirschot J.T. Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. J. Gen. Virol. 71:1990;1591-1595.
44. Moormann, R.J.M., Van Rijn, P.A., De Smit, A.J., Wensvoort, G., Terpstra, C., 1996. Recent developments in pig vaccinology. Proc. 14th Int. Pig Vet. Soc. Congr., Bologna, pp. 25-29.
45. Paton D.J., Ibata G., Edwards S., Wensvoort G. An ELISA detecting antibody to conserved pestivirus epitopes. J. Virol. Methods. 31:1991;315-324.
46. Pellerin C., Van den Hurk J., Lecomte J., Tijssen P. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology. 203:1994;260-268.
47. Smedegaard Madsen E., Madsen K.G., Nielsen J., Holm Jensen M., Lei J.C., Have P. Detection of antibodies against porcine parvovirus nonstructural protein NS1 may distinguish between vaccinated and infected pigs. Vet. Microbiol. 54:1997;1-16.
48. Stegeman J.A. Pseudorabies virus eradication by area-wide vaccination is feasible. Vet. Q. 17:1995;150-156.
49. Stegeman J.A., Van Nes A., De Jong M.C.M., Bolder F.W.M.M. Assessment of the effectiveness of vaccination against pseudorabies in finishing pigs. Am. J. Vet. Res. 56:1995;573-578.
50. Stegeman J.A., De Jong M.C.M., Van Nes A., Bouma A. Dynamics of pseudorabies virus infections in vaccinated pig populations: a review. Vet. Q. 19:1997;117-122.
51. Stegeman J.A., De Jong M.C.M., Van der Heijden H.M.J.F., Elbers A.R.W., Kimman T.G. Evaluation of tests for detection of antibodies to Aujeszky's disease (pseudorabies) virus glycoprotein E in the target population. Vet. Microbiol. 55:1997;107-111.
52. Straver P.J., Journée D.L.H., Binkhorst G.J. Neurological disorders, virus persistence and hypomyelination in calves due to intrauterine infections with bovine virus diarrhoea virus. II. Virology and epizootiology. Vet. Q. 5:1983;156-164.
53. Van Drunen Littel-van den Hurk S., Van Donkersgoed J., Kowalski J., Van den Hurk J.V., Harland R., Babiuk L.A., Zamb T.J. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine. 12:1994;1295-1302.
54. Van Nes A., Stegeman J.A., De Jong M.C.M., Loeffen W.L.A., Kimman T.G., Verheijden J.H.M. No major outbreaks of pseudorabies virus in well-immunized sow herds. Vaccine. 14:1996;1042-1044.
55. Vannier P., Eloit M.E., Gouello L., Le Bail P., Toma B. Epidemiological studies of the persistence of Aujeszky's disease virus between and within herds in France. Prev. Vet. Med. 11:1991;115-123.
56. Van Oirschot J.T. Induction of antibodies to glycoprotein I in (vaccinated) pigs exposed to different doses of a mild-virulent strain of Aujeszky's disease virus. Vet. Rec. 121:1988;599-603.
57. Van Oirschot J.T., Gielkens A.L.J. In vivo and in vitro reactivation of latent pseudorabies virus in pigs born to vaccinated sows. Am. J. Vet. Res. 45:1984;567-571.
58. Van Oirschot J.T., Terpstra C. A congenital persistent swine fever infection. I. Clinical and virological observations. Vet. Microbiol. 2:1977;121-132.
59. Van Oirschot J.T., Rziha H.J., Moonen P.J.L.M., Pol J.M.A., Van Zaane D. Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J. Gen. Virol. 67:1986;1179-1182.
60. Van Oirschot J.T., Gielkens A.L.J., Moormann R.J.M., Berns A.J.M. Marker vaccines, virus protein-specific assays and the control of Aujeszky's disease. Vet. Microbiol. 23:1990;85-101.
61. Van Oirschot J.T., Kaashoek M.J., Rijsewijk F.A.M. Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Vet. Microbiol. 53:1996;43-54.
62. Van Oirschot J.T., Kaashoek M.J., Rijsewijk F.A.M., Stegeman J.A. The use of marker vaccines in eradication of herpesviruses. J. Biotechnol. 44:1996;75-81.
63. Van Oirschot J.T., Kaashoek M.J., Maris-Veldhuis M.A., Weerdmeester K., Rijsewijk F.A.M. An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle. J. Virol. Methods. 67:1997;23-34.
64. Van Oirschot J.T., Bruschke C.J.M., Van Rijn P.A. Vaccination of cattle against bovine virus diarrhoea. Vet. Microbiol. 64:1999;169-183.
65. Van Rijn P.A., Van Gennip H.G.P., Leendertse C.H., Bruschke C.J.M., Paton D.J., Moormann R.J.M., Van Oirschot J.T. Subdivision of the pestivirus genus based on envelope glycoprotein E2. Virology. 237:1997;337-348.
66. Van Zijl M., Wensvoort G., De Kluyver E., Hulst M., Van der Gulden H., Gielkens A., Berns A., Moormann R. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine from both pseudorabies and hog cholera. J. Virol. 65:1991;2761-2765.
67. Wellenberg G.J., Verstraten E.R.A.M., Mars M.H., Van Oirschot J.T. Detection of bovine herpesvirus 1 glycoprotein E antibodies in individual milk samples by enzyme-linked immunosorbent assays. J. Clin. Microbiol. 36:1998;409-413.
68. Wentink G.H., Van Oirschot J.T., Verhoeff J. Risk of infection with bovine herpesvirus 1 (BHV1): a review. Vet. Q. 15:1993;30-33.
69. Wittmann G., Ohlinger V., Höhn U. Multiplication of Aujeszky's disease virus after experimental infection with high and low doses of virus. Zbl. Vet. Med. B. 29:1982;663-675.